Loading...
Market
What will be the next major medical condition treated using CiPSC technology by end of 2024?
2
Resolution / Starting Odds
Parkinson's Disease • 25%
Heart Disease • 25%
Spinal Cord Injury • 25%
Other • 25%
Official publications from reputable scientific journals
Story
Chinese Scientists Cure 25-Year-Old Woman of Type 1 Diabetes Using Stem Cells
Sep 27, 2024, 10:55 AM
Chinese scientists have achieved a groundbreaking clinical cure for a type 1 diabetes patient by transplanting islet cells derived from chemically induced pluripotent stem cells (CiPSC-islets). This procedure, published in the journal Cell, marks the first time a patient has been treated using reprogrammed stem cells extracted from their own body. A 25-year-old woman, who underwent the procedure in June 2023, started producing her own insulin less than three months after doctors injected about 1.5 million stem cell clusters into her abdominal muscles in a 30-minute procedure. She has maintained this insulin production for over a year without the need for supplements.
View original story
Similar markets
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
Cell • 25%
Nature • 25%
The Lancet • 25%
Other • 25%
Cancer treatment • 25%
Neurodegenerative diseases • 25%
Infectious diseases • 25%
Cardiovascular diseases • 25%
Approval for clinical trials in the US • 25%
Approval for clinical trials in Europe • 25%
Successful treatment of another patient • 25%
No major milestone achieved • 25%
Age-related macular degeneration • 25%
Diabetic retinopathy • 25%
Retinitis pigmentosa • 25%
No other application • 25%
0-4 • 25%
5-9 • 25%
10-14 • 25%
15 or more • 25%
United States • 25%
China • 25%
European Union • 25%
Other • 25%
Cancer • 33%
Neurodegenerative diseases • 33%
Cardiovascular diseases • 33%
Cancer • 25%
Cardiovascular disease • 25%
Neurological disorder • 25%
Other • 25%